TicoVac® (tick-borne encephalitis virus adsorbed)
What is TicoVac and what is it used for?
TicoVac 0.5 ml is a vaccine for the active (prophylactic) immunisation of people aged 16 years or older against tick-borne encephalitis (TBE). TicoVac Junior 0.25 ml is indicated for children aged between 1 and 15 years of age.
TicoVac help protects against TBE virus, a member of the flavivirus family that can affect the central nervous system. TBE virus is transmitted to humans by the bite of an infected tick and is almost exclusively restricted to areas of Europe and Asia.
How does the vaccine work?
TicoVac contains the Tick-Borne Encephalitis Virus which is inactivated using formaldehyde and itself cannot cause disease. The individual's immune system is stimulated by the inactivated virus, producing antibodies against it which in turn provides them with protection against TBE.
When should the vaccine be administered?
TicoVac 0.5 ml and TicoVac Junior 0.25 ml is to be given on the basis of official recommendations regarding the need for, and timing of, vaccination against TBE.
As with all vaccines, TicoVac and TicoVac Junior may not protect everyone who is fully vaccinated.
The medicine can only be obtained with a prescription.
If you would like to see the Patient Information Leaflet or Summary of Product Characteristics for TicoVac or TicoVac Junior these can be found at the electronic Medicines Compendium (eMC).
If you would like to see the latest information on vaccines and vaccination procedures for TicoVac and TicoVac Junior in the UK, please visit The Green Book.
PP-TCV-GBR-0103 / October 2021